Cintas Looks Flawlessly Executed — But That Flawlessness Is Priced In
Cintas (CTAS) remains a high-quality, cash-generative business with double-digit ROE and consistent growth. Recent execution and a proposed UniFirst acquisition have been bullish catalysts, but the stock at ~$193 trades at ~41x earnings and >7x sales, leaving little margin for error. This trade idea recommends a short on strength with a mid-term ho…